{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,22]],"date-time":"2026-09-22T02:03:42Z","timestamp":1790042622704,"version":"4.0.1"},"reference-count":32,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"1","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Indian Dermatol Online J"],"published-print":{"date-parts":[[2013]]},"DOI":"10.4103\/2229-5178.105488","type":"journal-article","created":{"date-parts":[[2013,1,3]],"date-time":"2013-01-03T06:13:48Z","timestamp":1357193628000},"page":"54","source":"Crossref","is-referenced-by-count":29,"title":["Topical rapamycin (sirolimus) for facial angiofibromas"],"prefix":"10.4103","volume":"4","author":[{"given":"Bhushan","family":"Madke","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"key-10.4103\/2229-5178.105488-1","first-page":"1886","volume-title":"The mTOR signalling pathway in human cancer","author":"P\u00f3pulo","year":"2012","journal-title":"Int J Mol Sci"},{"key":"key-10.4103\/2229-5178.105488-2","first-page":"2554","volume-title":"[Conversion from a calcineurin inhibitor to a sirolimus-based therapy after renal transplantation - An update of existing recommendations]","author":"Arns","year":"2011","journal-title":"Dtsch Med Wochenschr"},{"key":"key-10.4103\/2229-5178.105488-3","unstructured":"Dobashi Y, Watanabe Y, Miwa C, Suzuki S, Koyama S. Mammalian target of rapamycin: A central node of complex signaling cascades. Int J Clin Exp Pathol 2011;4:476-95."},{"key":"key-10.4103\/2229-5178.105488-4","first-page":"6373","volume-title":"Stress and mTORture signaling","author":"Reiling","year":"2006","journal-title":"Oncogene"},{"key":"key-10.4103\/2229-5178.105488-5","first-page":"3343","volume-title":"An emerging role for TOR signaling in mammalian tissue and stem cell physiology","author":"Russell","year":"2011","journal-title":"Development"},{"key":"key-10.4103\/2229-5178.105488-6","first-page":"241","volume-title":"Mammalian target of rapamycin inhibitors for treatment in tuberous sclerosis","author":"Kim","year":"2011","journal-title":"Korean J Pediatr"},{"key":"key-10.4103\/2229-5178.105488-7","first-page":"490","volume-title":"Rapamycin causes regression of astrocytomas in tuberous sclerosis complex","author":"Franz","year":"2006","journal-title":"Ann Neurol"},{"key":"key-10.4103\/2229-5178.105488-8","first-page":"140","volume-title":"Sirolimus for angiomyolipoma in tuberous sclerosis complex or lymphangioleiomyomatosis","author":"Bissler","year":"2008","journal-title":"N Engl J Med"},{"key":"key-10.4103\/2229-5178.105488-9","first-page":"660","volume-title":"Rapamune (Sirolimus, rapamycin): An overview and mechanism of action","author":"Sehgal","year":"1995","journal-title":"Ther Drug Monit"},{"key":"key-10.4103\/2229-5178.105488-10","first-page":"471","volume-title":"TOR signaling in growth and metabolism","author":"Wullschleger","year":"2006","journal-title":"Cell"},{"key":"key-10.4103\/2229-5178.105488-11","first-page":"1044","volume-title":"Everolimus: A proliferation signal inhibitor with clinical applications in organ transplantation, oncology, and cardiology","author":"Gabardi","year":"2010","journal-title":"Pharmacotherapy"},{"key":"key-10.4103\/2229-5178.105488-12","first-page":"1068","volume-title":"Sirolimus for calcineurin inhibitors in organ transplantation: Contra","author":"Cravedi","year":"2010","journal-title":"Kidney Int"},{"key":"key-10.4103\/2229-5178.105488-13","first-page":"912","volume-title":"A topical combination of rapamycin and tacrolimus for the treatment of angiofibroma due to tuberous sclerosis complex (TSC): A pilot study of nine Japanese patients with TSC of different disease severity","author":"Wataya-Kaneda","year":"2011","journal-title":"Br J Dermatol"},{"key":"key-10.4103\/2229-5178.105488-14","doi-asserted-by":"crossref","unstructured":"DeKlotz CM, Ogram AE, Singh S, Dronavalli S, MacGregor JL. Dramatic improvement of facial angiofibromas in tuberous sclerosis with topical rapamycin: Optimizing a treatment protocol. Arch Dermatol 2011;147:1116-7.","DOI":"10.1001\/archdermatol.2011.254"},{"key":"key-10.4103\/2229-5178.105488-15","first-page":"292","volume-title":"Effects of rapamycin on angiomyolipomas in patients with tuberous sclerosis","author":"Cabrera","year":"2011","journal-title":"Nefrologia"},{"key":"key-10.4103\/2229-5178.105488-16","first-page":"470","volume-title":"Lymphangioleiomyomatosis treatment with sirolimus","author":"Casanova","year":"2011","journal-title":"Arch Bronconeumol"},{"key":"key-10.4103\/2229-5178.105488-17","first-page":"1595","volume-title":"; National Institutes of Health Rare Lung Diseases Consortium; MILES Trial Group.Efficacy and safety of sirolimus in lymphangioleiomyomatosis","author":"McCormack","year":"2011","journal-title":"N Engl J Med"},{"key":"key-10.4103\/2229-5178.105488-18","first-page":"189","volume-title":"Potential of mTOR inhibitors for the treatment of subependymal giant cell astrocytomas in tuberous sclerosis complex","author":"Major","year":"2011","journal-title":"Aging (Albany NY)"},{"key":"key-10.4103\/2229-5178.105488-19","first-page":"1238","volume-title":"Regression of subependymal giant cell astrocytoma with rapamycin in tuberous sclerosis complex","author":"Koenig","year":"2008","journal-title":"J Child Neurol"},{"key":"key-10.4103\/2229-5178.105488-20","first-page":"835","volume-title":"mTOR inhibitors in advanced renal cell carcinoma","author":"Voss","year":"2011","journal-title":"Hematol Oncol Clin North Am"},{"key":"key-10.4103\/2229-5178.105488-21","first-page":"1","volume-title":"mTOR inhibitors: A novel class of anti-cancer agents","author":"Riaz","year":"2012","journal-title":"Infect Agent Cancer"},{"key":"key-10.4103\/2229-5178.105488-22","first-page":"654","volume-title":"Kaposi\u2032s sarcoma resolves after sirolimus therapy in a patient with pemphigus vulgaris","author":"Saggar","year":"2008","journal-title":"Arch Dermatol"},{"key":"key-10.4103\/2229-5178.105488-23","first-page":"758","volume-title":"Treatment of psoriasis with topical sirolimus: Preclinical development and a randomized, double-blind trial","author":"Ormerod","year":"2005","journal-title":"Br J Dermatol"},{"key":"key-10.4103\/2229-5178.105488-24","doi-asserted-by":"crossref","unstructured":"Soria A, Agbo-Godeau S, Ta\u00efeb A, Franc\u00e8s C. Treatment of refractory oral erosive lichen planus with topical rapamycin: 7 cases. Dermatology 2009;218:22-5.","DOI":"10.1159\/000172830"},{"key":"key-10.4103\/2229-5178.105488-25","unstructured":"Official website of US FDA. Available from URL: http:\/\/www.accessdata.fda.gov\/drugsatfda_docs\/label\/2008\/021083s033,021110s043lbl.pdf [Last accessed on 2012 Mar 22]."},{"key":"key-10.4103\/2229-5178.105488-26","first-page":"5549","volume-title":"Antiangiogenic potential of the Mammalian target of rapamycin inhibitor temsirolimus","author":"Del","year":"2006","journal-title":"Cancer Res"},{"key":"key-10.4103\/2229-5178.105488-27","first-page":"715","volume-title":"A novel approach to facial angiofibromas in tuberous sclerosis","author":"Haemel","year":"2010","journal-title":"Arch Dermatol"},{"key":"key-10.4103\/2229-5178.105488-28","first-page":"922","volume-title":"Treatment of facial angiofibromas with topical application of oral rapamycin solution (1 mgmL(-1)) in two patients with tuberous sclerosis","author":"Mutizwa","year":"2011","journal-title":"Br J Dermatol"},{"key":"key-10.4103\/2229-5178.105488-29","doi-asserted-by":"crossref","unstructured":"Truchuelo T, D\u00edaz-Ley B, R\u00edos L, Alc\u00e1ntara J, Ja\u00e9n P. Facial angiofibromas treated with topical rapamycin: An excellent choice with fast response. Dermatol Online J 2012;18:15.","DOI":"10.5070\/D36TB7N61M"},{"key":"key-10.4103\/2229-5178.105488-30","first-page":"52","volume-title":"Topical 0.1% rapamycin for angiofibromas in paediatric patients with tuberous sclerosis: A pilot study of four patients","author":"Foster","year":"2012","journal-title":"Australas J Dermatol"},{"key":"key-10.4103\/2229-5178.105488-31","doi-asserted-by":"crossref","unstructured":"Salido R, Garnacho-Saucedo G, Cuevas-Asencio I, Ruano J, Gal\u00e1n-Gutierrez M, V\u00e9lez A, et al. Sustained clinical effectiveness and favorable safety profile of topical sirolimus for tuberous sclerosis - associated facial J Eur Acad Dermatol Venereol. 2011 Aug 11. doi: 10.1111\/j.1468-3083.2011.04212.x.","DOI":"10.1111\/j.1468-3083.2011.04212.x"},{"key":"key-10.4103\/2229-5178.105488-32","first-page":"46","volume-title":"Successful treatment of angiofibromata of tuberous sclerosis complex with rapamycin","author":"Kaufman","year":"2012","journal-title":"J Dermatolog Treat"}],"container-title":["Indian Dermatology Online Journal"],"original-title":[],"language":"en","deposited":{"date-parts":[[2026,8,13]],"date-time":"2026-08-13T14:54:11Z","timestamp":1786632851000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/10.4103\/2229-5178.105488"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013]]},"references-count":32,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2013]]}},"alternative-id":["105488"],"URL":"https:\/\/doi.org\/10.4103\/2229-5178.105488","relation":{},"ISSN":["2229-5178"],"issn-type":[{"value":"2229-5178","type":"print"}],"subject":[],"published":{"date-parts":[[2013]]}}}